img

Global Acute Hepatic Porphyria Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Acute Hepatic Porphyria Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Acute hepatic porphyria drugs are used for the treatment of adult patients with acute hepatic porphyria.
Acute Hepatic Porphyria Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Acute Hepatic Porphyria Drug market is projected to reach US$ 5 million in 2029, increasing from US$ 4 million in 2022, with the CAGR of 5.0% during the period of 2024 to 2029. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acute Hepatic Porphyria Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Alnylam Pharmaceuticals
Recordati Rare Diseases
Segment by Type
350 Mg
313 Mg

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Acute Hepatic Porphyria Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Acute Hepatic Porphyria Drug introduction, etc. Acute Hepatic Porphyria Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Acute Hepatic Porphyria Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Acute Hepatic Porphyria Drug
1.1 Acute Hepatic Porphyria Drug Market Overview
1.1.1 Acute Hepatic Porphyria Drug Product Scope
1.1.2 Acute Hepatic Porphyria Drug Market Status and Outlook
1.2 Global Acute Hepatic Porphyria Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Acute Hepatic Porphyria Drug Market Size by Region (2018-2029)
1.4 Global Acute Hepatic Porphyria Drug Historic Market Size by Region (2018-2024)
1.5 Global Acute Hepatic Porphyria Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Acute Hepatic Porphyria Drug Market Size (2018-2029)
1.6.1 North America Acute Hepatic Porphyria Drug Market Size (2018-2029)
1.6.2 Europe Acute Hepatic Porphyria Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Acute Hepatic Porphyria Drug Market Size (2018-2029)
1.6.4 Latin America Acute Hepatic Porphyria Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Acute Hepatic Porphyria Drug Market Size (2018-2029)
2 Acute Hepatic Porphyria Drug Market by Type
2.1 Introduction
2.1.1 350 Mg
2.1.2 313 Mg
2.2 Global Acute Hepatic Porphyria Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Acute Hepatic Porphyria Drug Historic Market Size by Type (2018-2024)
2.2.2 Global Acute Hepatic Porphyria Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Acute Hepatic Porphyria Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Acute Hepatic Porphyria Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Acute Hepatic Porphyria Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Acute Hepatic Porphyria Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Acute Hepatic Porphyria Drug Revenue Breakdown by Type (2018-2029)
3 Acute Hepatic Porphyria Drug Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacy
3.1.2 Retail Pharmacy
3.1.3 Online Pharmacy
3.1.4 Others
3.2 Global Acute Hepatic Porphyria Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Acute Hepatic Porphyria Drug Historic Market Size by Application (2018-2024)
3.2.2 Global Acute Hepatic Porphyria Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Acute Hepatic Porphyria Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Acute Hepatic Porphyria Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Acute Hepatic Porphyria Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Acute Hepatic Porphyria Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Acute Hepatic Porphyria Drug Revenue Breakdown by Application (2018-2029)
4 Acute Hepatic Porphyria Drug Competition Analysis by Players
4.1 Global Acute Hepatic Porphyria Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Hepatic Porphyria Drug as of 2022)
4.3 Date of Key Players Enter into Acute Hepatic Porphyria Drug Market
4.4 Global Top Players Acute Hepatic Porphyria Drug Headquarters and Area Served
4.5 Key Players Acute Hepatic Porphyria Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Acute Hepatic Porphyria Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Alnylam Pharmaceuticals
5.1.1 Alnylam Pharmaceuticals Profile
5.1.2 Alnylam Pharmaceuticals Main Business
5.1.3 Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Products, Services and Solutions
5.1.4 Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Alnylam Pharmaceuticals Recent Developments
5.2 Recordati Rare Diseases
5.2.1 Recordati Rare Diseases Profile
5.2.2 Recordati Rare Diseases Main Business
5.2.3 Recordati Rare Diseases Acute Hepatic Porphyria Drug Products, Services and Solutions
5.2.4 Recordati Rare Diseases Acute Hepatic Porphyria Drug Revenue (US$ Million) & (2018-2024)
5.2.5 Recordati Rare Diseases Recent Developments
6 North America
6.1 North America Acute Hepatic Porphyria Drug Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Acute Hepatic Porphyria Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Acute Hepatic Porphyria Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Acute Hepatic Porphyria Drug Market Dynamics
11.1 Acute Hepatic Porphyria Drug Industry Trends
11.2 Acute Hepatic Porphyria Drug Market Drivers
11.3 Acute Hepatic Porphyria Drug Market Challenges
11.4 Acute Hepatic Porphyria Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Acute Hepatic Porphyria Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Acute Hepatic Porphyria Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Acute Hepatic Porphyria Drug Market Size Share by Region (2018-2024)
Table 4. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Acute Hepatic Porphyria Drug Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Acute Hepatic Porphyria Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Acute Hepatic Porphyria Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Acute Hepatic Porphyria Drug Revenue Market Share by Type (2018-2024)
Table 9. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Acute Hepatic Porphyria Drug Revenue Market Share by Type (2024-2029)
Table 11. North America Acute Hepatic Porphyria Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Acute Hepatic Porphyria Drug Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Acute Hepatic Porphyria Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Acute Hepatic Porphyria Drug Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Acute Hepatic Porphyria Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Acute Hepatic Porphyria Drug Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Acute Hepatic Porphyria Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Acute Hepatic Porphyria Drug Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Acute Hepatic Porphyria Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Acute Hepatic Porphyria Drug Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Acute Hepatic Porphyria Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Acute Hepatic Porphyria Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Acute Hepatic Porphyria Drug Revenue Market Share by Application (2018-2024)
Table 24. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Acute Hepatic Porphyria Drug Revenue Market Share by Application (2024-2029)
Table 26. North America Acute Hepatic Porphyria Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Acute Hepatic Porphyria Drug Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Acute Hepatic Porphyria Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Acute Hepatic Porphyria Drug Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Acute Hepatic Porphyria Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Acute Hepatic Porphyria Drug Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Acute Hepatic Porphyria Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Acute Hepatic Porphyria Drug Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Acute Hepatic Porphyria Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Acute Hepatic Porphyria Drug Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Acute Hepatic Porphyria Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Acute Hepatic Porphyria Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Hepatic Porphyria Drug as of 2022)
Table 39. Date of Key Players Enter into Acute Hepatic Porphyria Drug Market
Table 40. Global Acute Hepatic Porphyria Drug Key Players Headquarters and Area Served
Table 41. Acute Hepatic Porphyria Drug Product Solution and Service
Table 42. Global Acute Hepatic Porphyria Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Alnylam Pharmaceuticals Basic Information List
Table 45. Alnylam Pharmaceuticals Description and Business Overview
Table 46. Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Acute Hepatic Porphyria Drug Business of Alnylam Pharmaceuticals (2018-2024)
Table 48. Alnylam Pharmaceuticals Recent Developments
Table 49. Recordati Rare Diseases Basic Information List
Table 50. Recordati Rare Diseases Description and Business Overview
Table 51. Recordati Rare Diseases Acute Hepatic Porphyria Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Acute Hepatic Porphyria Drug Business of Recordati Rare Diseases (2018-2024)
Table 53. Recordati Rare Diseases Recent Developments
Table 54. North America Acute Hepatic Porphyria Drug Market Size by Country (2018-2024) & (US$ Million)
Table 55. North America Acute Hepatic Porphyria Drug Market Size by Country (2024-2029) & (US$ Million)
Table 56. Europe Acute Hepatic Porphyria Drug Market Size by Country (2018-2024) & (US$ Million)
Table 57. Europe Acute Hepatic Porphyria Drug Market Size by Country (2024-2029) & (US$ Million)
Table 58. Asia-Pacific Acute Hepatic Porphyria Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 59. Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region (2018-2024) & (US$ Million)
Table 60. Asia-Pacific Acute Hepatic Porphyria Drug Market Size by Region (2024-2029) & (US$ Million)
Table 61. Asia-Pacific Acute Hepatic Porphyria Drug Market Share by Region (2018-2024)
Table 62. Asia-Pacific Acute Hepatic Porphyria Drug Market Share by Region (2024-2029)
Table 63. Latin America Acute Hepatic Porphyria Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 64. Latin America Acute Hepatic Porphyria Drug Market Size by Country (2018-2024) & (US$ Million)
Table 65. Latin America Acute Hepatic Porphyria Drug Market Size by Country (2024-2029) & (US$ Million)
Table 66. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 67. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country (2018-2024) & (US$ Million)
Table 68. Middle East & Africa Acute Hepatic Porphyria Drug Market Size by Country (2024-2029) & (US$ Million)
Table 69. Acute Hepatic Porphyria Drug Market Trends
Table 70. Acute Hepatic Porphyria Drug Market Drivers
Table 71. Acute Hepatic Porphyria Drug Market Challenges
Table 72. Acute Hepatic Porphyria Drug Market Restraints
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Hepatic Porphyria Drug Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Acute Hepatic Porphyria Drug Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Acute Hepatic Porphyria Drug Market Share by Regions: 2022 VS 2029
Figure 4. Global Acute Hepatic Porphyria Drug Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Acute Hepatic Porphyria Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Acute Hepatic Porphyria Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Acute Hepatic Porphyria Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Acute Hepatic Porphyria Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Acute Hepatic Porphyria Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of 350 Mg
Figure 11. Global 350 Mg Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of 313 Mg
Figure 13. Global 313 Mg Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Acute Hepatic Porphyria Drug Market Size Share by Type: 2022 & 2029
Figure 15. North America Acute Hepatic Porphyria Drug Revenue Market Share by Type (2018-2029)
Figure 16. Europe Acute Hepatic Porphyria Drug Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Acute Hepatic Porphyria Drug Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Acute Hepatic Porphyria Drug Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Acute Hepatic Porphyria Drug Revenue Market Share by Type (2018-2029)
Figure 20. Hospital Pharmacy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Retail Pharmacy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Online Pharmacy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Global Acute Hepatic Porphyria Drug Market Size Share by Application: 2022 & 2029
Figure 25. North America Acute Hepatic Porphyria Drug Revenue Market Share by Application (2018-2029)
Figure 26. Europe Acute Hepatic Porphyria Drug Revenue Market Share by Application (2018-2029)
Figure 27. Asia-Pacific Acute Hepatic Porphyria Drug Revenue Market Share by Application (2018-2029)
Figure 28. Latin America Acute Hepatic Porphyria Drug Revenue Market Share by Application (2018-2029)
Figure 29. Middle East and Africa Acute Hepatic Porphyria Drug Revenue Market Share by Application (2018-2029)
Figure 30. Acute Hepatic Porphyria Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 31. Global Top 5 and Top 10 Players Acute Hepatic Porphyria Drug Market Share in 2022
Figure 32. North America Acute Hepatic Porphyria Drug Market Share by Country (2018-2029)
Figure 33. United States Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 34. Canada Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 35. Germany Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 36. France Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 37. U.K. Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 38. Italy Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 39. Russia Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 40. Nordic Countries Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 41. Asia-Pacific Acute Hepatic Porphyria Drug Market Share by Region (2018-2029)
Figure 42. China Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 43. Japan Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 44. South Korea Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 46. India Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 47. Australia Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 48. Latin America Acute Hepatic Porphyria Drug Market Share by Country (2018-2029)
Figure 49. Mexico Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 50. Brazil Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Acute Hepatic Porphyria Drug Market Share by Country (2018-2029)
Figure 52. Turkey Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 54. UAE Acute Hepatic Porphyria Drug Market Size (2018-2029) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries